WASHINGTON, D.C. – A new analysis released today by the nonpartisan Tax Foundation reports that the return of the medical device excise tax would lead to a loss of 21,390 U.S. medical technology jobs and a $1.74 billion decline in the nation’s GDP.
WASHINGTON, D.C. – A coalition of major U.S. business groups is calling on Congress to repeal the medical device excise tax before it comes back into effect at the end of this year, triggering a $20 billion tax increase on the medical technology industry.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the introduction of legislation in the U.S. Senate by Sens. Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.) to improve Medicare beneficiaries’ access to innovative diabetes management technologies:
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) is launching a suite of tools and resources – including online training, credentialing and certification – to aid implementation of its updated Code of Ethics on Interactions with Health Care Professionals (HCPs) in the U.S. The revised code, which was unveiled in January 2019 and becomes effective on Jan. 1, 2020, reflects evolving legal standards, care delivery models and best practices over the last decade.
WASHINGTON, D.C. – As Congress prepares to address end-of-year spending decisions and other initiatives that are set to expire if not acted upon, the Advanced Medical Technology Association (AdvaMed) today released survey results showing that reinstatement of the medical device excise tax would bring job losses as well as declines in investment in research and development.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement today from President and CEO Scott Whitaker following release of air testing data from the Environmental Protection Agency (EPA) that looked at levels of ethylene oxide (EtO) across the country:
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today on CMS’s release of final CY 2020 Medicare payment rules – including the CY 2020 Medicare Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center final rule and the CY 2020 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule – that support patient access to medical technology innovation:
“The final OPPS and ESRD rule are good news for Medicare beneficiaries as they will help ensure America’s seniors have more timely access to breakthrough and new medtech innovations. The final rules make it easier for new breakthrough technologies to qualify for outpatient transitional passthrough payments in the outpatient hospital setting and for dialysis facilities to receive new add-on payments when using new innovative equipment and supplies that offer substantial improvements in care.
“These changes follow a similar provision in the FY 2020 inpatient hospital rule that AdvaMed has long supported. These rules highlight the continued commitment of HHS Secretary Azar, CMS Administrator Verma, and the Administration to spur access to innovative new technologies for the benefit of American patients.
“We look forward to working closely with CMS on implementation of these final rules, and additional ways to facilitate greater efficiencies in the coverage and payment process.”
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued a statement today from President and CEO Scott Whitaker regarding President Trump’s nomination of Dr. Stephen Hahn to serve as FDA Commissioner.
WASHINGTON, DC. – The Advanced Medical Technology Association (AdvaMed) was named one of the most effective trade associations in Washington, DC, according to the latest annual TradeMarks study released by APCO Worldwide, a leading international advocacy and communications consulting firm.
WASHINGTON, DC. – A top FDA official warned that additional closures of ethylene oxide (EtO) sterilization plants could lead to shortages of critical medical devices across the country.